Maha Othman on 10-Year Anniversary of the CanVECTOR Research Network!
Maha Othman, Editor-in-Chief of Current Opinion in Hematology Journal, Research Co-Lead at CanVECTOR Research Network, shared on LinkedIn:
”Amazing conference this past weekend marking the 10-Year Anniversary of the CanVECTOR Research Network!
I’m truly proud to be part of the Steering Committee, Co-Leading the Basic Science and Translation Research Platform, and supporting the next generation of researchers. Congratulations to all the trainees and winners of the 2025 Platform Competition!
Special thanks to the leaders at inception — Marc Rodgers and Susan Kahn — and to the current leadership team: Grégoire Le Gal and Deborah Siegal for their continued vision and guidance.
Especially proud of two of my trainees / mentees who presented posters at the conference:
Anne F.:
“Prognostic Accuracy of the Khorana and Caprini Thromboembolic Risk Assessment Models in Patients with Gynecological Tumours: A Meta-Analysis.”
This work was made possible through the contributions of my other mentees Abdelrahman Ahmed , Zein Hammad, Omar Hajjaj, Monzer Assar, as well as key statistical insights from Queen’s University and expert input from Dr. Kerstin DeWitt
Yousra Tera
“Thromboelastography and Haematological Parameters for Venous Thromboembolism Risk Prediction in Ovarian Cancer Patients.”
This sub-study stems from our larger Women’s Cancer Thrombosis Project, completed with fantastic collaboration from Queen’s Medical Oncology and GYN Oncology teams — Drs. Anita Agrawal, Rania Chehade, George Gray — and incredible support from NP Alexandra Stewart.
Congratulations to the conference co-chairs Amye Harrigan and Jameel Abdulrehman and the entire Planning Committee for an exceptional and rich program this year.
Proud to be part of this inspiring network and looking forward to continuing our collective work advancing thrombosis research and mentorship.”
Stay updated with Hemostasis Today.
-
Oct 28, 2025, 14:27Maha Othman on 10-Year Anniversary of the CanVECTOR Research Network!
-
Oct 28, 2025, 14:00Claudio Laudani on PCSK9 Association with Increased Platelet Reactivity: A Pooled Analysis
-
Oct 28, 2025, 13:31Laurent Bertoletti Invites You to The INNOVTE and GITA Joined Meeting on Hormones and Thrombosis
-
Oct 28, 2025, 12:28Courtney Lawrence: Honored to Team Up with BET on Blood at AABB 2025
-
Oct 27, 2025, 19:45Benedikt Lorenz on Liver Failure and Coagulation – Myths, Traps, and Bad Habits
-
Oct 28, 2025, 13:09Gregory Piazza on CORONA-VTE Network Analysis
-
Oct 27, 2025, 18:42Khaled Musallam Shares BEYOND Trial Phase 2 Insights on Luspatercept Use in NTD β-Thalassaemia
-
Oct 27, 2025, 13:30Fabrice Cognasse: When Platelets Meet Artificial Intelligence!
-
Oct 27, 2025, 13:00Hossam El Benawi Shares Multi Site LVT Study from Mayo Clinic
-
Oct 27, 2025, 08:01Acquired Hemophilia A (AHA) is Rare and Often Missed - RPTH Journal
-
Oct 25, 2025, 07:42Adithya Hande: India’s Silent Killer and a Scientific Breakthrough
-
Oct 23, 2025, 09:57Arun V. J: Artificial Blood Is Closer Than You Think
-
Oct 23, 2025, 07:11Sebastien Lobet Presented the ACTIVLIM-Hemo Scale
-
Oct 23, 2025, 07:05Syed Ehsan Shah on Advantages of Werfen HemoCell Automation
-
Oct 22, 2025, 08:25Johanna Nystedt: Not Every Day We Can Release a New Blood Product to Meet An Unmet Medical Need!
-
Oct 27, 2025, 15:10David McIntosh Reflects on International Plasma Awareness Week
-
Oct 27, 2025, 13:18Stroke Foundation Welcomes Jacqui McCallum as the New Executive Director
-
Oct 27, 2025, 12:54Guillermo Lahera Forteza on Stroke and Mental Health
-
Oct 27, 2025, 12:37Joshua Ngimbwa Recognised as the Best Male Junior Investigator Awardee at the Tanzania Health Summit
-
Oct 27, 2025, 08:00Rohit Gosain: Revumenib is Now FDA Approved for R/R AML with NPM1 Mutation